Research Paper Volume 16, Issue 17 pp 12392—12413
RPL22L1 is a novel biomarker for prognosis and immune infiltration in lung adenocarcinoma, promoting the growth and metastasis of LUAD cells by inhibiting the MDM2/P53 signaling pathway
Figure 5. Spearman correlation analysis of MSI/TMB and mRNAsi and RPL22L1 gene expression in LUAD. (A) MSI. (B) TMB. (C) mRNAsi. The figure displays the gene expression distribution on the horizontal coordinates and the mRNAsi distribution on the vertical coordinates. The density curve on the right side represents the trend of the mRNAsi distribution, while the density curve on the upper side represents the trend of the gene expression distribution. The uppermost values in the figure indicate the correlation p-value, correlation coefficient, and the method used for correlation calculation.